Aryl-alkyl-lysines: Membrane-Active Small Molecules Active against Murine Model of Burn Infection

ACS Infect Dis. 2016 Feb 12;2(2):111-22. doi: 10.1021/acsinfecdis.5b00092. Epub 2015 Dec 11.

Abstract

Infections caused by drug-resistant Gram-negative pathogens continue to be significant contributors to human morbidity. The recent advent of New Delhi metallo-β-lactamase-1 (blaNDM-1) producing pathogens, against which few drugs remain active, has aggravated the problem even further. This paper shows that aryl-alkyl-lysines, membrane-active small molecules, are effective in treating infections caused by Gram-negative pathogens. One of the compounds of the study was effective in killing planktonic cells as well as dispersing biofilms of Gram-negative pathogens. The compound was extremely effective in disrupting preformed biofilms and did not select resistant bacteria in multiple passages. The compound retained activity in different physiological conditions and did not induce any toxic effect in female Balb/c mice until concentrations of 17.5 mg/kg. In a murine model of Acinetobacter baumannii burn infection, the compound was able to bring the bacterial burden down significantly upon topical application for 7 days.

Keywords: Gram-negative; antibiotics; antimicrobial peptides; antimicrobial resistance; biofilm; burn infection; persisters.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acinetobacter baumannii / drug effects*
  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Biofilms / drug effects
  • Burns / microbiology*
  • Disease Models, Animal
  • Drug Resistance, Bacterial
  • Female
  • Lysine / analogs & derivatives*
  • Lysine / pharmacology*
  • Mice
  • Mice, Inbred BALB C
  • Microbial Sensitivity Tests
  • Wound Infection / microbiology*
  • beta-Lactamases / metabolism

Substances

  • Anti-Bacterial Agents
  • beta-Lactamases
  • beta-lactamase NDM-1
  • Lysine